KURA CIK: 1422143

Kura Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.52
FY22:
0.45
FY23:
0.43
FY24:
0.74
FY25:
0.71
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.01
FY23:
0.02
FY24:
0.02
FY25:
0.03
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.53
FY22:
0.46
FY23:
0.45
FY24:
0.76
FY25:
0.74

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.02
FY23:
0.04
FY24:
0.08
FY25:
0.12
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.01
FY23:
0.02
FY24:
0.27
FY25:
0.45
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.51
FY22:
0.42
FY23:
0.40
FY24:
0.41
FY25:
0.17
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.53
FY22:
0.46
FY23:
0.45
FY24:
0.76
FY25:
0.74

All amounts in billions USD Data source:SEC EDGAR